Reaching for aggressive blood pressure goals: Role of angiotensin receptor blockade in combination therapy

Milani, R. V. (2005) Reaching for aggressive blood pressure goals: Role of angiotensin receptor blockade in combination therapy. American Journal of Managed Care, 11 7: S220-S227.

Author Milani, R. V.
Title Reaching for aggressive blood pressure goals: Role of angiotensin receptor blockade in combination therapy
Journal name American Journal of Managed Care
ISSN 1088-0224
1936-2692
Publication date 2005-09
Sub-type Article (original research)
Volume 11
Issue 7
Start page S220
End page S227
Total pages 8
Place of publication Plainsboro, NJ, United States
Publisher Managed Care & Healthcare Communications
Language eng
Abstract Elevated blood pressure, particularly systolic blood pressure, increases the risk of cardiovascular and renal complications in patients with diabetes. Current national guidelines set the blood pressure goal for those with diabetes at <130/80 mm Hg, which is lower than the goal for the general population (<140/90 mm Hg). Achieving this goal, however, remains difficult, with blood pressure control rates being lower for patients with diabetes than for those without diabetes. Large clinical trials have demonstrated that in most cases, patients will require 2 or more antihypertensive agents to achieve goal blood pressure. The renin-angiotensin-aldosterone system plays a key role in regulation of blood pressure. The angiotensin AT1 receptor blockers (ARBs), which block the effects of angiotensin II, not only lower blood pressure but also provide target-organ protection. These agents are generally well-tolerated, with a side effect profile similar to placebo. Clinical comparisons of different drugs within the class have shown that olmesartan, the newest ARB, produced greater reductions in blood pressure than other agents and that a greater percentage of patients treated with olmesartan reached target blood pressure. Combining an ARB with a diuretic may allow more patients to reach goal blood pressure.
Keyword TO-MODERATE HYPERTENSION
RANDOMIZED-TRIAL
DOUBLE-BLIND
ANTIHYPERTENSIVE THERAPY
SYSTOLIC HYPERTENSION
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 15 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Mon, 14 Mar 2011, 09:51:24 EST